Speaker

Mary Spellman

Chief Medical Officer, Panclarity

Mary Spellman, Chief Medical Officer at Panclarity, is speaking at 10th Dermatology Drug Development Summit (Boston, United States of America, 3–5 Nov 2026) in the session “Workshop B: Rare & Ultra-Rare Inflammatory Skin Disease: Exploring Under-Researched Populations to Address High Unmet Need & Unlock Scalable Innovation”.

Conferences: 1
Keynotes: 0
Upcoming: 1

Upcoming appearances

10th Dermatology Drug Development Summit
3–5 Nov 2026Boston, United States of America
- WorkshopWorkshop B: Rare & Ultra-Rare Inflammatory Skin Disease: Exploring Under-Researched Populations to Address High Unmet Need & Unlock Scalable InnovationWith Karen McGuire, Akanksha Mittal

More speakers at 10th Dermatology Drug Development Summit

Mudgal Kothekar
Vice President Clinical Development, Sun Pharma Advanced Research Company Ltd.
Maria Akerman
Director, Global Programs, Affibody AB
John Armstrong
Head of Healthcare Banking, Westpark Capital
Frederick Beddingfield
Chief Executive Officer & Director, Rubedo Life Sciences
Dan Brownell
Senior Director, AOBiome
Kenneth Crook
Head of Translational Medicine, Engimmune Therapeutics

See all 30 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Mary Spellman, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].